Drugs index in alphabetical orders:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Ginette 35 with/out a prior prescriptions order at lowest prices on the WWW: Ginette 35
Brand name: GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) Pronounced: Eva-loon Generic name: Estradiol vaginal ring GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) (Estradiol, Estrace Vaginal) Why is GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) prescribed?
GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) is an estrogen replacement system for relief of the vaginal problems that often occur after menopause, including vaginal dryness, burning, and itching, and difficult or painful intercourse. GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) is also prescribed for postmenopausal urinary problems such as difficulty urinating or urinary urgency. Most important fact about GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone)
Estrogens increase the risk of cancer in the lining of the uterus, called the endometrium. Because estrogen replacement therapy is not advisable if you are in any danger of developing cancer, your doctor should take a complete medical and family history, and perform a complete physical exam, before prescribing GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone). It is important to have regular check-ups (at least once a year) and to report any unusual vaginal bleeding to your doctor immediately.
GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) and other estrogen drugs, with or without progesterone, should not be used to prevent heart disease. Recent studies have confirmed an increased rate of heart attack, stroke, and dangerous blood clots among women taking estrogen or estrogen combinations for 5 years. Blood clots can lead to phlebitis, stroke, heart attack, a loss of blood supply to the lungs, a blockage in the blood vessels leading to the eye, and other serious disorders. How should you use GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) (Estradiol, Estrace Vaginal) without prescriptions?
Each GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) is left in place for 3 months. Press the GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) into an oval and insert it as deeply as possible into the upper third of the vagina. The exact position is unimportant as long as you don't feel the ring. If the ring causes discomfort, it is probably not far enough inside.
If the ring slips down into the lower part of the vagina, push it back up with your finger. If it falls out, rinse it in warm water and reinsert it. When replacing the ring, simply hook a finger through it and pull it out.
If you miss a dose...
If the ring is not replaced after 90 days, the dose of estrogen will gradually decline and your symptoms will return.
Storage instructions...
Store at room temperature. GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) (Estradiol, Estrace Vaginal) side effects
Side effects cannot be anticipated. If any develop or change in intensity, tell your doctor as soon as possible. Only your doctor can determine if it is safe for you to continue using GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone).
* Side effects may include: Abdominal pain, arthritis, back pain, flu-like symptoms, headaches, insomnia, joint pain, nausea, sinus inflammation, upper respiratory tract infections, vaginal discharge, vaginal discomfort or pain, vaginal inflammation or bleeding, yeast infection
Why should GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) not be prescribed?
Do not use GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) if you have unexplained vaginal bleeding. Also avoid GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) if there is a possibility that you are pregnant.
Do not use GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) if there is any chance that you have breast cancer or any other cancer stimulated by estrogen. You will also have to avoid GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) if it causes an allergic reaction. Special warnings about GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone)
Estrogen replacement therapy increases the risk of developing cancer of the lining of the uterus. The risk increases with longer use and higher doses. Therefore, you should use GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) for as short a time and at as low a dose as is necessary to relieve your symptoms. Report any unusual vaginal bleeding to you doctor immediately.
Using estrogen may also increase the risk of breast cancer, ovarian cancer, heart attack, stroke, blood clots, and gallbladder disease.
Use estrogen with caution if you have severely low blood levels of calcium (hypocalcemia).
Tell your doctor if you've ever had liver problems, high cholesterol, high blood pressure, thyroid problems, or visions problems. Using estrogen could make these conditions worse.
Estrogens can cause water retention. If you have a condition that could be affected by this--such as heart or kidney problems--your doctor will monitor you closely
While using GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone), contact your doctor right away if you develop any of the following:
Abdominal pain, tenderness, or swelling Abnormal bleeding from the vagina Breast lumps Coughing up blood Difficulty with speech Dizziness or faintness Pains in your chest or calves Severe headache or vomiting Sudden shortness of breath Vision changes Weakness or numbness of an arm or leg Yellowing of skin or whites of the eyes (could signal a liver problem)
Any vaginal infection should be cleared up before you begin GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) therapy. If an infection develops after you begin, you'll need to remove the ring during treatment. Possible food and drug interactions when using GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone)
No interactions have been reported, but GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) should be removed during treatment with other vaginally administered drugs. Special information if you are pregnant or breastfeeding
GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) must not be used during pregnancy and is not intended for nursing mothers. Recommended dosage for GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone)
Insert a new ring every 3 months. Overdosage
An overdose from GINETTE 35 (Diane 35, Ethinylestradiol/Cyproterone) is unlikely. An oral overdose of estrogen could be expected to cause the symptoms listed below.
* Symptoms of estrogen overdose may include: Nausea, vomiting, vaginal bleeding
Product lndex drugs